I agree that this site is using cookies. You can find further informations here.
X
Mease, Philip J.
770  results:
Search for persons X
?
1

Maternal-fetal outcomes in patients with immune-mediated in..:

Hwang, Yeon Mi ; Wei, Qi ; Piekos, Samantha N....
eClinicalMedicine.  68 (2024)  - p. 102435 , 2024
Link: https://doi.org/10.1016/..
 
?
2

The Burden of Work Productivity and Activity Impairment in ..:

Janak, Jud C. ; Loughlin, Anita M. ; Moore, Page C....
Digestive Diseases and Sciences.  , 2024
Link: https://doi.org/10.1007/..
 
?
3

Correction: Exploring the Effects of Ixekizumab on Pain in ..:

de Vlam, Kurt ; Maksymowych, Walter P. ; Gallo, Gaia...
Rheumatology and Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

Guselkumab provides durable improvement across psoriatic ar..:

Coates, Laura C ; Gossec, Laure ; Zimmermann, Miriam...
RMD Open.  10 (2024)  1 - p. e003977 , 2024
Link: https://doi.org/10.1136/..
 
?
5

Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA..:

Ribeiro, Andre L ; Singla, Shikha ; Chandran, Vinod...
Rheumatology Advances in Practice.  8 (2024)  3 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
6

EULAR recommendations for the management of psoriatic arthr..:

Gossec, Laure ; Kerschbaumer, Andreas ; Ferreira, Ricardo J O...
Annals of the Rheumatic Diseases.  , 2024
Link: https://doi.org/10.1136/..
 
?
7

Safety of Secukinumab from 1 Million Patient-Years of Expos..:

Sun, Rui ; Bustamante, Mercedes ; Gurusamy, Venkatesh Kumar...
Dermatology and Therapy.  14 (2024)  3 - p. 729-743 , 2024
Link: https://doi.org/10.1007/..
 
?
8

Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Bi..:

FitzGerald, Oliver ; Gladman, Dafna D. ; Mease, Philip J....
Arthritis & Rheumatology.  , 2024
Link: https://doi.org/10.1002/..
 
?
9

Evaluating the efficacy of biologics with and without metho..:

Mease, Philip J ; Reddy, Soumya ; Ross, Sarah...
RMD Open.  10 (2024)  1 - p. e003423 , 2024
Link: https://doi.org/10.1136/..
 
?
10

Exploring the Effects of Ixekizumab on Pain in Patients wit..:

de Vlam, Kurt ; Maksymowych, Walter P. ; Gallo, Gaia...
Rheumatology and Therapy.  11 (2024)  3 - p. 691-707 , 2024
Link: https://doi.org/10.1007/..
 
?
11

Continuous improvement through differential trajectories of..:

Coates, Laura C. ; Rahman, Proton ; Mease, Philip J....
BMC Rheumatology.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
12

Effectiveness of Tofacitinib in Patients Initiating Therapy..:

Mease, Philip J. ; Young, Pamela ; Fallon, Lara...
Rheumatology and Therapy.  11 (2024)  2 - p. 313-329 , 2024
Link: https://doi.org/10.1007/..
 
?
13

BASDAI versus ASDAS in evaluating axial involvement in pati..:

Baraliakos, Xenofon ; Gladman, Dafna D ; Chakravarty, Soumya D...
Rheumatology Advances in Practice.  8 (2024)  2 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
14

P171 Bimekizumab impact on core group for research and asse..:

Merola, Joseph F ; Mease, Philip J ; Deodhar, Atul...
Rheumatology.  63 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
15

Patients with Psoriatic Arthritis at Biologic Therapy Switc..:

Mease, Philip ; Jones, Eric ; Sima, Adam...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s311 , 2024
Link: https://doi.org/10.25251..
 
1-15